Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory

[1]  S. M. Hwang,et al.  Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia , 2021, International journal of laboratory hematology.

[2]  M. Béné,et al.  Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer , 2021, Cancers.

[3]  A. Shestakova,et al.  Automated leukocyte parameters are useful in the assessment of myelodysplastic syndromes , 2020, Cytometry. Part B, Clinical cytometry.

[4]  H. Harmouche,et al.  Immature platelets: a review of the available evidence. , 2020, Thrombosis research.

[5]  M. Boubaya,et al.  A novel complete blood count‐based score to screen for myelodysplastic syndrome in cytopenic patients , 2018, British journal of haematology.

[6]  M. Boubaya,et al.  A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice , 2018, Scandinavian journal of clinical and laboratory investigation.

[7]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[8]  Y. Yatomi,et al.  Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia , 2015, Hematology.

[9]  J. Hoffmann.  Reticulated platelets: analytical aspects and clinical utility , 2014, Clinical chemistry and laboratory medicine.

[10]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[11]  C. Cogle,et al.  Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. , 2011, Blood.

[12]  K. Ishiyama,et al.  Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis , 2009, European journal of haematology.

[13]  K. Saigo,et al.  Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes. , 2009, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[14]  P W Barnes,et al.  The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. , 2005, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[15]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[16]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[17]  A. Trowbridge,et al.  Myelodysplastic Syndrome: Identification in the Routine Hematology Laboratory , 1987, Southern medical journal.